Literature DB >> 3184764

Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B.

M Oppermann1, M Haubitz, E Quentin, O Götze.   

Abstract

Using sensitive and highly specific enzyme-linked immunosorbent assays fragments of the complement proteins C3, C5, and factor B were quantitated in patients with renal failure. During hemodialysis on new cuprophan membranes raised levels not only of C3a, but in addition of activated C3, C5a, and Ba were demonstrated. In patients with chronic renal failure and end-stage renal disease plasma concentrations of Ba and activated C3 were markedly elevated independent of hemodialysis. This finding is taken as an indication of a continuous recruitment of the alternative pathway of complement in these patients. As the detected complement protein fragments are known to exert immune regulatory functions these findings may imply that these peptides are involved in the maintenance of the immune suppressed state in renal failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3184764     DOI: 10.1007/bf01728947

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

Review 1.  Immunologic alterations in chronic renal insufficiency.

Authors:  J P Revillard
Journal:  Adv Nephrol Necker Hosp       Date:  1979

2.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

3.  Serum complement in acute nephritis.

Authors:  R READER
Journal:  Br J Exp Pathol       Date:  1948-06

4.  A sensitive ELISA for the quantitation of human C5a in blood plasma using a monoclonal antibody.

Authors:  M Schulze; O Götze
Journal:  Complement       Date:  1986

Review 5.  Modulation of the immune response by anaphylatoxins.

Authors:  E L Morgan
Journal:  Complement       Date:  1986

Review 6.  Clinical utility of complement anaphylatoxin assays.

Authors:  D E Hammerschmidt
Journal:  Complement       Date:  1986

7.  Growth control of activated, synchronized murine B cells by the C3d fragment of human complement.

Authors:  F Melchers; A Erdei; T Schulz; M P Dierich
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

8.  Quantitation of human complement fragment C4ai in physiological fluids by competitive inhibition radioimmune assay.

Authors:  J P Gorski
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids.

Authors:  J L Wagner; T E Hugli
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

10.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  4 in total

1.  Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters.

Authors:  Edimara S Reis; Robert A DeAngelis; Hui Chen; Ranillo R G Resuello; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2014-11-03       Impact factor: 3.144

2.  Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.

Authors:  M Oppermann; O Götze
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

3.  Moraxella lacunata septic arthritis in a patient with lupus nephritis.

Authors:  Anna Woodbury; James Jorgensen; Aaron Owens; Andres Henao-Martinez
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

Review 4.  Role of complement in multiorgan failure.

Authors:  Daniel Rittirsch; Heinz Redl; Markus Huber-Lang
Journal:  Clin Dev Immunol       Date:  2012-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.